Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maggie C U Cheang

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Cancers|February 12, 2021
Lights and Shadows in Immuno-Oncology Drug DevelopmentMilana Bergamino Sirvén, Sonia Pernas, Maggie C U Cheang
Annual Review of Pathology|November 28, 2007
Gene expression profiling of breast cancerMaggie C U Cheang, Matt van de Rijn, Torsten O Nielsen
Radiation Research|February 18, 2014
Radiation-induced gene signature predicts pathologic complete response to neoadjuvant chemotherapy in breast cancer patientsDaniel S Oh, Maggie C U Cheang, Cheng Fan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
Breast cancer subtypes and the risk of local and regional relapseK David Voduc, Maggie C U Cheang, Scott Tyldesley, et al.
The Oncologist|February 14, 2013
Molecular characterization of basal-like and non-basal-like triple-negative breast cancerAleix Prat, Barbara Adamo, Maggie C U Cheang, et al.
Breast Cancer Research and Treatment|February 12, 2009
Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patientsShuzhen Liu, Stephen K Chia, Erika Mehl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotypeMaggie C U Cheang, David Voduc, Chris Bajdik, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 23, 2005
Assessment of Her-1, Her-2, And Her-3 expression and Her-2 amplification in advanced stage ovarian carcinomaCheng-Han Lee, David G Huntsman, Maggie C U Cheang, et al.
Clinical Breast Cancer|July 25, 2008
Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancerSimon J Crabb, Maggie C U Cheang, Samuel Leung, et al.
Molecular Cancer Therapeutics|October 12, 2018
A Four-gene Decision Tree Signature Classification of Triple-negative Breast Cancer: Implications for Targeted TherapeuticsJelmar Quist, Hasan Mirza, Maggie C U Cheang, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Cancers|February 12, 2021
Lights and Shadows in Immuno-Oncology Drug DevelopmentMilana Bergamino Sirvén, Sonia Pernas, Maggie C U Cheang
Annual Review of Pathology|November 28, 2007
Gene expression profiling of breast cancerMaggie C U Cheang, Matt van de Rijn, Torsten O Nielsen
Radiation Research|February 18, 2014
Radiation-induced gene signature predicts pathologic complete response to neoadjuvant chemotherapy in breast cancer patientsDaniel S Oh, Maggie C U Cheang, Cheng Fan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
Breast cancer subtypes and the risk of local and regional relapseK David Voduc, Maggie C U Cheang, Scott Tyldesley, et al.
The Oncologist|February 14, 2013
Molecular characterization of basal-like and non-basal-like triple-negative breast cancerAleix Prat, Barbara Adamo, Maggie C U Cheang, et al.
Breast Cancer Research and Treatment|February 12, 2009
Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patientsShuzhen Liu, Stephen K Chia, Erika Mehl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotypeMaggie C U Cheang, David Voduc, Chris Bajdik, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 23, 2005
Assessment of Her-1, Her-2, And Her-3 expression and Her-2 amplification in advanced stage ovarian carcinomaCheng-Han Lee, David G Huntsman, Maggie C U Cheang, et al.
Clinical Breast Cancer|July 25, 2008
Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancerSimon J Crabb, Maggie C U Cheang, Samuel Leung, et al.
Molecular Cancer Therapeutics|October 12, 2018
A Four-gene Decision Tree Signature Classification of Triple-negative Breast Cancer: Implications for Targeted TherapeuticsJelmar Quist, Hasan Mirza, Maggie C U Cheang, et al.
Pageof 5